We are live on ! Find out more
B

Barings Portfolio holdings

AUM $6.19B
1-Year Est. Return 16.5%
This Fund
S&P 500
This Quarter Est. Return
+8.46%
1 Year Est. Return
+16.5%
3 Year Est. Return
+50.95%
5 Year Est. Return
+53.21%
10 Year Est. Return
+287.68%
AUM
$2.4B
AUM Growth
+$64.5M
Cap. Flow
-$473M
Cap. Flow %
-19.74%
Top 10 Hldgs %
19.06%
Holding
1,040
New
104
Increased
254
Reduced
395
Closed
121

Sector Composition

Rank Sector Weight
1 Financials 12.05%
2 Industrials 10.4%
3 Healthcare 9.34%
4 Consumer Discretionary 8.65%
5 Energy 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
51
Amgen
AMGN
$210B
$7.58M 0.32%
66,386
+9,300
+16% +$1.06M
MA icon
52
Mastercard
MA
$502B
$7.53M 0.31%
90,110
-15,700
-15% -$1.17M
MDT icon
53
Medtronic
MDT
$112B
$7.4M 0.31%
129,017
+15,900
+14% +$902K
OMN
54
DELISTED
OMNOVA Solutions Inc.
OMN
$7.26M 0.3%
797,342
UNH icon
55
UnitedHealth
UNH
$385B
$7.24M 0.3%
96,145
+600
+0.6% +$43.1K
COP icon
56
ConocoPhillips
COP
$144B
$7.1M 0.3%
100,432
-17,855
-15% -$1.28M
UNP icon
57
Union Pacific
UNP
$173B
$7.08M 0.3%
84,328
-64,024
-43% -$5.07M
HPQ icon
58
HP
HPQ
$26.1B
$6.92M 0.29%
544,196
+18,497
+4% +$212K
KMP
59
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$6.89M 0.29%
85,455
+2,400
+3% +$194K
OXY icon
60
Occidental Petroleum
OXY
$55.8B
$6.74M 0.28%
73,967
+50,623
+217% +$4.62M
WBA
61
DELISTED
Walgreens Boots Alliance
WBA
$6.74M 0.28%
117,263
+44,600
+61% +$2.59M
CNMD icon
62
CONMED
CNMD
$1.31B
$6.72M 0.28%
158,150
-44,500
-22% -$1.69M
CELG
63
DELISTED
Celgene Corp
CELG
$6.66M 0.28%
78,794
-5,080
-6% -$402K
ELV icon
64
Elevance Health
ELV
$82.4B
$6.49M 0.27%
70,214
+6,400
+10% +$569K
EPD icon
65
Enterprise Products Partners
EPD
$84B
$6.35M 0.27%
191,610
-16,000
-8% -$498K
RTX icon
66
RTX Corp
RTX
$294B
$6.31M 0.26%
88,113
+13,506
+18% +$921K
MO icon
67
Altria Group
MO
$126B
$6.14M 0.26%
160,070
+19,200
+14% +$709K
IART icon
68
Integra LifeSciences
IART
$1.35B
$6.01M 0.25%
308,422
-518,931
-63% -$9.52M
ARCC icon
69
Ares Capital
ARCC
$13.6B
$6.01M 0.25%
338,200
LOW icon
70
Lowe's Companies
LOW
$122B
$6M 0.25%
121,024
-37,900
-24% -$1.84M
FCX icon
71
Freeport-McMoran
FCX
$85.4B
$5.86M 0.24%
155,175
+18,825
+14% +$667K
F icon
72
Ford
F
$61.4B
$5.85M 0.24%
379,375
-16,800
-4% -$282K
USB icon
73
US Bancorp
USB
$99B
$5.8M 0.24%
143,699
+53,600
+59% +$2.06M
SMA
74
DELISTED
SYMMETRY MEDICAL INC
SMA
$5.78M 0.24%
573,710
+88,510
+18% +$770K
PSX icon
75
Phillips 66
PSX
$83.6B
$5.78M 0.24%
74,874
+16,500
+28% +$1.1M

Similar funds

Barings's Q4 2013 Portfolio in Review

As of Q4 2013, Barings held 1,040 positions worth $2.4B, up 2.8% from $2.33B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Barings withdrew a net $473M in Q4 2013, closing 121 positions and reducing 395 holdings. Its most notable exit was Hillenbrand, an estimated $9.91M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Barings opened a new position in Usg worth $8.19M.

  • Barings's largest Q4 2013 buy was Usg: 288,700 shares worth $8.19M.
  • Barings added most to Intel in Q4 2013, an estimated $5.57M increase.
  • Barings's biggest Q4 2013 reduction was Integra LifeSciences, cutting an estimated $9.52M.
  • Barings fully exited Hillenbrand in Q4 2013, selling an estimated $9.91M.
  • Barings's ten largest holdings make up 19% of its $2.4B portfolio in Q4 2013.
  • Barings opened 104 new positions and closed 121 in Q4 2013.
  • Barings's portfolio value rose 2.8% quarter-over-quarter to $2.4B.

Based on Barings's 13F filing for Q4 2013, filed 14 Feb 2014.